Search Results 6021-6030 of 25146 for oral

1. Phase 1/2 Study Of MRTX1719 In Solid Tumors With MTAP Deletion - Mayo Clinic

   swallow oral medications. - Cardiac abnormalities. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 11/10/23 ...

2. Probing the molecular drivers of meningioma - Mayo Clinic

   Oral medications might be possible eventually, as meningiomas lie outside the blood-brain barrier. "The issues of drug delivery that affect glioblastoma ...

3. A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism - Mayo Clinic

   Use of bisphosphonates (oral or IV) or denosumab within 2 years prior to Visit 1. 9. Non-hypocalcemic seizure disorder with a history of a seizure within 26 ...

4. MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma - Mayo Clinic

   * Subjects on prior intravenous therapy (e.g., chemotherapy or checkpoint inhibitors), or prior oral therapy (e.g.,proto-oncogene B-RAF or mitogen-activated ...

5. Salivary gland tumors - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...

6. A Study to Investigate Intravenous Tocilizumab in Patients with Moderate-to-Severe COVID-19 Pneumonia (enrolling by invitation only) - Mayo Clinic

   Receipt of oral anti-rejection or immunomodulatory drugs (including TCZ) within the past 3 months;; Participation in other drug clinical trials ...

7. PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies - Mayo Clinic

   Highly effective methods of birth control include hormonal birth control (oral, intravaginal, transdermal, implantable, or intrauterine), intrauterine ...

8. A Study of Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients with Previously Treated Multiple Myeloma or Plasma Cell Leukemia - Mayo Clinic

   ... oral absorption or tolerance of ixazomib including difficulty swallowing; Diarrhea > grade 1, based on the National Cancer Institute Common Terminology ...

9. Efficacy and Safety of Maribavir in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment - Mayo Clinic

   ... oral/enteral medication. Have known hypersensitivity to the active substance or to an excipient for a study treatment. Have tissue invasive CMV disease with ...

10. Diabetic nephropathy (kidney disease) - Doctors and departments - Mayo Clinic

    Research at Mayo Clinic in diabetic nephropathy includes developing new diagnostic and treatment tools, such as oral medicines that may help stop or delay ...